Story thread · 14 reports / 9 sources
AI-designed drug may slow signs of human aging
qazinform.com · 4d
How the coverage leans
Across 9 sources · syndicated copies counted once
An artificial intelligence -designed drug being developed for a serious lung disease showed signs of reducing patients' biological age in a small clinical trial, according to a study in Nature Biotechnology, Qazinform News Agency correspondent reports.
First report: STAT+: Roivant lung disease drug hits mid-stage study goals — statnews.com, 7d
The coverage
- Can a Drug to Treat Lung Disease Slow Biological Aging? A 12-Week Trial Found Early Signs
inc.com · 4d
- Lung transplants in older adults grew 13-fold: 6 notes
beckershospitalreview.com · 5d
The conversation · 0
Sign in to join the conversation.
No comments yet — start the thread.